V-GO DISPOSABLE INSULIN DELIVERY DEVICE V-GO 40

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 04,consumer report with the FDA on 2014-08-18 for V-GO DISPOSABLE INSULIN DELIVERY DEVICE V-GO 40 manufactured by Valeritas, Llc..

Event Text Entries

[4726007] It was reported to valeritas customer care that diabetic patient (pt). Type 2 using the v-go 40 since (b)(6) 2014 experienced an abscess on his abdomen while using the v-go. According to the valeritas adverse event (ae) assessor, the patient stated that on (b)(6)2014, he removed the v-go from his left abdominal area, noticed a red mark and after a few days the red mark became "much larger, was hot, hard and very painful to touch". Patient reports he went to the emergency room on (b)(6) 2014, the abscess was drained and packed. Patient was not hospitalized. Patient states the drainage is still continuing (patient was not able to describe drainage amount or color), the site is very red and tender, the size of silver dollar. Patient was given a prescription and instructed to start antibiotics immediately (name of antibiotic unknown by patient), however patient has not filled the antibiotic prescription and states he will not be able to start the antibiotic till (b)(6) 2014 due to financial reasons. Ae assessor instructed patient to contact his hcp right away to discuss with hcp that he has not started the antibiotic. Patient is currently off the v-go for financial reasons, he was not discontinued from v-go by hcp.
Patient Sequence No: 1, Text Type: D, B5


[12179674] This mdr is being submitted per our procedure. Patient experienced an adverse event in the form of an abscess (on abdomen) at application site. Patient went to the emergency room where the abscess was drained and packed (medical intervention) to prevent further complications. The device was not available for investigation. Even though the v-go is terminally sterilized, there is always the possibility of infection at the application site and site preparation. Diabetics are also prone to infection.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number1226572-2014-00008
MDR Report Key4036900
Report Source04,CONSUMER
Date Received2014-08-18
Date of Report2014-07-25
Date of Event2014-07-18
Date Mfgr Received2014-07-25
Date Added to Maude2014-08-27
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactSCOTT HUIE
Manufacturer Street800 BOSTON TURNPIKE
Manufacturer CitySHREWSBURY MA 01545
Manufacturer CountryUS
Manufacturer Postal01545
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameV-GO DISPOSABLE INSULIN DELIVERY DEVICE
Generic NameV-GO
Product CodeKZE
Date Received2014-08-18
Model NumberV-GO 40
Lot NumberUNKNOWN
OperatorLAY USER/PATIENT
Device Availability*
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerVALERITAS, LLC.
Manufacturer Address750 ROUTE 202 SOUTH SUITE 100 BRIDGEWATER NJ 088072597 US 088072597


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 2014-08-18

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.